BX Swiss TOP 30 CHF
1.215,17
PKT
-12,87
PKT
-1,05
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
28.07.17 | Nestlé buy | Goldman Sachs Group Inc. | |
28.07.17 | UBS buy | Deutsche Bank AG | |
28.07.17 | UBS Hold | Deutsche Bank AG | |
27.07.17 | Nestlé buy | UBS AG | |
27.07.17 | Roche Neutral | UBS AG | |
27.07.17 | Roche Outperform | Bernstein Research | |
26.07.17 | Holcim Neutral | UBS AG | |
26.07.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
26.07.17 | Novartis overweight | Morgan Stanley | |
26.07.17 | Roche Equal-Weight | Morgan Stanley | |
25.07.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
25.07.17 | Givaudan Sell | Société Générale Group S.A. (SG) | |
25.07.17 | Swiss Re buy | Deutsche Bank AG | |
25.07.17 | UBS buy | HSBC | |
24.07.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
24.07.17 | Givaudan Neutral | UBS AG | |
24.07.17 | Novartis buy | Jefferies & Company Inc. | |
21.07.17 | Givaudan buy | Baader Bank | |
21.07.17 | Givaudan Neutral | BNP PARIBAS | |
21.07.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
21.07.17 | Givaudan overweight | JP Morgan Chase & Co. | |
21.07.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
21.07.17 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
21.07.17 | Swiss Re overweight | Morgan Stanley | |
21.07.17 | ABB (Asea Brown Boveri) Hold | Kepler Cheuvreux | |
21.07.17 | Givaudan Neutral | Goldman Sachs Group Inc. | |
21.07.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
21.07.17 | Givaudan Hold | Deutsche Bank AG | |
21.07.17 | Givaudan verkaufen | Bernstein Research | |
20.07.17 | Roche overweight | JP Morgan Chase & Co. | |
20.07.17 | UBS buy | Deutsche Bank AG | |
20.07.17 | UBS Hold | Deutsche Bank AG | |
20.07.17 | Holcim Hold | Deutsche Bank AG | |
20.07.17 | ABB (Asea Brown Boveri) Hold | S&P Capital IQ | |
20.07.17 | Novartis Neutral | UBS AG | |
20.07.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
19.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
19.07.17 | UBS buy | UBS AG | |
19.07.17 | Novartis Outperform | Bernstein Research | |
19.07.17 | Novartis buy | Société Générale Group S.A. (SG) |